Medicis Capital

Total investments

6

Average round size

18M

Portfolio companies

4

Follow on index

0.33

Exits

3

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyInformation TechnologyHealth CareHealth DiagnosticsMedicalPharmaceuticalTherapeuticsBioinformatics

Summary

The company was established in Europe in Germany. The main department of described Corporate Investor is located in the Munich.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Medicis Capital, startups are often financed by Nexus Medical Partners, Innoven Partners, Ventech. The meaningful sponsors for the fund in investment in the same round are Ventech, Saratoga Ventures, Nexus Medical Partners. In the next rounds fund is usually obtained by Valiance Asset Management, Accuitive Medical Ventures, Yorkville Advisors.

The top activity for fund was in 2010. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Medicis Capital is 100-500 millions dollars. This Medicis Capital works on 38 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.

The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Hybrigenics, EyeGate Pharmaceuticals, MyoScience Among the most popular fund investment industries, there are Health Diagnostics, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
6
Lead investments
0
Exits
3
Follow on index
0.33
Investments by industry
  • Biotechnology (6)
  • Pharmaceutical (4)
  • Therapeutics (3)
  • Medical (2)
  • Information Technology (1)
  • Show 3 more
Investments by region
  • United States (4)
  • France (1)
  • United Kingdom (1)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
44M
Group Appearance index
0.83
Avg. company exit year
9
Avg. multiplicator
4.41

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Hybrigenics 01 Dec 2001 Biotechnology, Therapeutics, Bioinformatics Early Stage Venture 15M Ile-de-France, Paris, France

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.